Nutrition, Metabolism & Cardiovascular Diseases
Volume 21, Issue 9 , Pages 691-698 , September 2011

Association of the FTO gene variant (rs9939609) with cardiovascular disease in men with abnormal glucose metabolism – The Finnish Diabetes Prevention Study

  • T. Lappalainen

      Affiliations

    • School of Public Health and Clinical Nutrition, Department of Clinical Nutrition and Food and Health Research Centre, University of Kuopio, P.O. Box 1627, 70211 Kuopio, Finland
    • Corresponding Author InformationCorresponding author. Tel.: +358 40 355 3607; fax: +358 17 162 792.
    • ,
  • M. Kolehmainen

      Affiliations

    • School of Public Health and Clinical Nutrition, Department of Clinical Nutrition and Food and Health Research Centre, University of Kuopio, P.O. Box 1627, 70211 Kuopio, Finland
    • ,
  • U.S. Schwab

      Affiliations

    • School of Public Health and Clinical Nutrition, Department of Clinical Nutrition and Food and Health Research Centre, University of Kuopio, P.O. Box 1627, 70211 Kuopio, Finland
    • Institute of Medicine, Department of Internal Medicine, Kuopio University Hospital and University of Kuopio, Kuopio, Finland
    • ,
  • A.M. Tolppanen

      Affiliations

    • School of Public Health and Clinical Nutrition, Department of Clinical Nutrition and Food and Health Research Centre, University of Kuopio, P.O. Box 1627, 70211 Kuopio, Finland
    • ,
  • A. Stančáková

      Affiliations

    • Institute of Medicine, Department of Internal Medicine, Kuopio University Hospital and University of Kuopio, Kuopio, Finland
    • ,
  • J. Lindström

      Affiliations

    • Diabetes Unit, Department of Health Promotion and Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland
    • Department of Public Health, University of Helsinki, Helsinki, Finland
    • ,
  • J.G. Eriksson

      Affiliations

    • Diabetes Unit, Department of Health Promotion and Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland
    • Department of General Practice and Primary Health Care, University of Helsinki, Helsinki, Finland
    • Helsinki University Hospital, Unit of General Practice, Helsinki, Finland
    • Vasa Central Hospital, Vasa and Folkhälsan Research Unit, Helsinki, Finland
    • ,
  • S. Keinänen-Kiukaanniemi

      Affiliations

    • Oulu University Hospital and Health Centre, Oulu Deaconess Institute and Institute of Health Sciences, University of Oulu, Oulu, Finland
    • ,
  • S. Aunola

      Affiliations

    • National Institute for Health and Welfare, Living Conditions, Health and Wellbeing Unit, Turku, Finland
    • ,
  • P. Ilanne-Parikka

      Affiliations

    • Diabetes Centre of the Finnish Diabetes Association and the Research Unit of Tampere University Hospital, Tampere, Finland
    • ,
  • C. Herder

      Affiliations

    • Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
    • ,
  • W. Koenig

      Affiliations

    • Department of Internal Medicine II – Cardiology, University of Ulm Medical Centre, Germany
    • ,
  • H. Gylling

      Affiliations

    • School of Public Health and Clinical Nutrition, Department of Clinical Nutrition and Food and Health Research Centre, University of Kuopio, P.O. Box 1627, 70211 Kuopio, Finland
    • Institute of Medicine, Department of Internal Medicine, Kuopio University Hospital and University of Kuopio, Kuopio, Finland
    • ,
  • H. Kolb

      Affiliations

    • Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
    • ,
  • J. Tuomilehto

      Affiliations

    • Diabetes Unit, Department of Health Promotion and Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland
    • Department of Public Health, University of Helsinki, Helsinki, Finland
    • ,
  • J. Kuusisto

      Affiliations

    • Institute of Medicine, Department of Internal Medicine, Kuopio University Hospital and University of Kuopio, Kuopio, Finland
    • ,
  • M. Uusitupa

      Affiliations

    • School of Public Health and Clinical Nutrition, Department of Clinical Nutrition and Food and Health Research Centre, University of Kuopio, P.O. Box 1627, 70211 Kuopio, Finland
    • ,
  • for the Finnish Diabetes Prevention Study Group

Received 4 August 2009 ,Revised 18 December 2009 ,Accepted 8 January 2010.

References 

  1. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316:889–894
  2. Scuteri A, Sanna S, Chen WM, Uda M, Albai G, Strait J, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007;3:e115
  3. Dina C, Meyre D, Gallina S, Durand E, Körner A, Jacobson P, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Gene. 2007;39:724–726
  4. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316:1341–1345
  5. Lappalainen TJ, Tolppanen AM, Kolehmainen M, Schwab U, Lindström J, Tuomilehto J, et al. The common variant in the FTO gene did not modify the effect of lifestyle changes on body weight – The Finnish Diabetes Prevention Study. Obesity. 2009;17:832–836
  6. Fisher E, Schulze MB, Stefan N, Häring HU, Döring F, Joost HG, et al. Association of the FTO rs9939609 single nucleotide polymorphism with C-reactive protein levels. Obesity. 2009;17:330–334
  7. Freathy RM, Timpson NJ, Lawlor DA, Pouta A, Ben-Shlomo Y, Ruokonen A, et al. Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes. 2008;57:1419–1426
  8. von Hundelshausen P, Weber KS, Huo Y, Proudfoot AE, Nelson PJ, Ley K, et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation. 2001;103:1772–1777
  9. Eriksson EE. Mechanisms of leukocyte recruitment to atherosclerotic lesions: future prospects. Curr Opin Lipidol. 2004;15:553–558
  10. Skurk T, Mack I, Kempf K, Kolb H, Hauner H, Herder C. Expression and secretion of RANTES (CCL5) in human adipocytes in response to immunological stimuli and hypoxia. Horm Metab Res. 2009;41:183–189
  11. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–1350
  12. Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368:1673–1679
  13. Eriksson J, Lindström J, Valle T, Aunola S, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia. 1999;42:793–801
  14. Herder C, Peltonen M, Koenig W, Kraft I, Muller-Scholze S, Martin S, et al. Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention Study. Diabetes. 2006;55:2340–2346
  15. Uusitupa M, Peltonen M, Lindström J, Aunola S, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, et al. Ten – year mortality and cardiovascular morbidity in the finnish Diabetes Prevention Study – secondary analysis of the randomized trial. PLoS One. 2009;4:e5656
  16. Wang J, Kuusisto J, Vanttinen M, Kuulasmaa T, Lindstrom J, Tuomilehto J, et al. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. Diabetologia. 2007;50:1192–1200
  17. World Health Organization . Definition, diagnosis and classification of diabetes: mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: Department of Noncommunicable Disease Surveillance; 1999;
  18. Doney ASF, Dannfald J, Kimber CH, Donnelly LA, Pearson E, Morris AD, et al. The FTO gene is associated with an atherogenic lipid profile and myocardial infarction in patients with Type 2 Diabetes: A Go-DARTS study. Circ Cardiovasc Genet. 2009;March 30
  19. Zimmermann E, Kring SI, Berentzen TL, Holst C, Pers TH, Hansen T, et al. Fatness-associated FTO gene variant increases mortality independent of fatness–in cohorts of Danish men. PLoS One. 2009;4:e4428
  20. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986;111:383–390
  21. Wingard DL, Suarez L, Barrett-Connor E. The sex differential in mortality from all causes and ischemic heart disease. Am J Epidemiol. 1983;117:165–172
  22. Jacobsson JA, Danielsson P, Svensson V, Klovins J, Gyllensten U, Marcus C, et al. Biochem Biophys Res Commun. 2008;368:476–482
  23. Kring SI, Holst C, Zimmermann E, Jess T, Berentzen T, Toubro S, et al. FTO gene associated fatness in relation to body fat distribution and metabolic traits throughout a broad range of fatness. PLoS One. 2008;3:e2958
  24. Zabena C, González-Sánchez JL, Martínez-Larrad MT, Torres-García A, Alvarez-Fernández-Represa J, Corbatón-Anchuelo A, et al. The FTO obesity gene. Genotyping and gene expression analysis in morbidly obese patients. Obes Surg. 2009;19:87–95
  25. Pausova Z, Syme CA, Abarahamowicz M, Xiao Y, Leonard GT, Perron M, et al. A common variant of the FTO gene is associated not only with increased adiposity but also elevated blood pressure in French-Canadians. Circ Cardiovasc Genet. 2009;March 31
  26. Fischer J, Koch L, Emmerling C, Vierkotten J, Peters T, Brüning JC, et al. Inactivation of the FTO gene protects from obesity. Nature. 2009;458:894–898
  27. Cecil JE, Tavendale R, Watt P, Hetherington MM, Palmer CN. An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med. 2008;359:2558–2566
  28. Timpson NJ, Emmett PM, Frayling TM, Rogers I, Hattersley AT, McCarthy MI, et al. The fat mass- and obesity-associated locus and dietary intake in children. Am J Clin Nutr. 2008;88:971–978
  29. Wardle J, Llewellyn C, Sanderson S, Plomin R. The FTO gene and measured food intake in children. Int J Obes. 2009;33:42–45
  30. Wardle J, Carnell S, Haworth CM, Farooqi IS, O'Rahilly S, Plomin R. Obesity associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab. 2008;93:3640–3643
  31. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, et al. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357:497–499
  32. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, et al. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007;316:1488–1491
  33. Erdmann J, Grosshennig A, Braund PS, König IR, Hengstenberg C, Hall AS, et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet. 2009;41:280–282

PII: S0939-4753(10)00014-1

doi: 10.1016/j.numecd.2010.01.006

Nutrition, Metabolism & Cardiovascular Diseases
Volume 21, Issue 9 , Pages 691-698 , September 2011

Article Tools

* Image Usage & Resolution